Defunct Company
Total Trials
1
As Lead Sponsor
0
As Collaborator
Total Enrollment
2,015
NCT00689156
Epirubicin or Not in Patients With TOP2A (Topoisomerase (DNA) II Alpha (170kD)) Normal Early Breast Cancer
Phase: Phase 3
Role: Collaborator
Start: Jun 30, 2008
Completion: Jan 31, 2013